Clinical Trial Results:
Ensayo clínico de fase III multicéntrico, randomizado, doble ciego, controlado con placebo, para comparar la eficacia de bevacizumab en combinación con rituximab y CHOP (RA CHOP) frente a rituximab y CHOP (R CHOP) en pacientes con linfoma difuso de células B grandes (LDCBG) CD20 positivo no tratados previamente. A multi-center, randomized, double-blind, placebo-controlled phase III trial omparing the efficacy of bevacizumab in combination with rituximab and CHOP (RA-CHOP) versus rituximab and CHOP (R-CHOP) in previously untreated patients with CD20-positive diffuse large B-cell lymphoma (DLBCL)

EudraCT number
Trial protocol
ES   AT   FR   CZ   GR   PT   GB   SE   DE   IT   PL   SK   LT   HU  
Global completion date
08 May 2012

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?

Results information
Results version number
This version publication date
08 Jul 2016
First version publication date
22 May 2015
Other versions
Summary report(s)
BO20603 (CTg receipt)
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.